Astellas US LLC et al v. Mylan Pharmaceuticals Inc. > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Dec 22, 2022 | 228 | AMENDED ORDER GRANTING JOINT MOTION TO SEAL (ECF. NO. 225 ). The Court GRANTS the motion and DIRECTS the parties to file the attachments to their joint pretrial order under seal. Signed by Chief District Judge Thomas S Kleeh on 12/22/2022. (dk) (Entered: 12/22/2022) (1) |
Dec 22, 2022 | 229 | STIPULATION AND ORDER OF DISMISSAL by Mylan Pharmaceuticals Inc.. (O'Brien, William) (Entered: 12/22/2022) (2) |
Dec 22, 2022 | 230 | ORDER granting 223 Motion of Elizabeth M. Flanagan for Leave to Appear Pro Hac Vice on behalf of Astellas Pharma US, Inc., Astellas US LLC. Signed by Chief District Judge Thomas S Kleeh on 12/22/2022. (dk) (Entered: 12/22/2022) (1) |
Dec 22, 2022 | 231 | STIPULATION AND ORDER OF DISMISSAL. Signed by Chief District Judge Thomas S Kleeh on 12/22/2022. (dk) (Entered: 12/22/2022) (2) |
Dec 21, 2022 | 227 | ORDER GRANTING JOINT MOTION TO SEAL (ECF. NO. 225 ). The Court GRANTS the motion and DIRECTS the parties to file their joint pretrial order and all attachments under seal. Signed by Chief District Judge Thomas S Kleeh on 12/21/2022. (dk) (Entered: 12/21/2022) (1) |
Dec 20, 2022 | 226 | Proposed Pretrial Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Higginbotham, Daniel) (Entered: 12/20/2022) (22) |
Dec 19, 2022 | 224 | Pro Hac Vice Filing fee: $ 200.00, receipt number WVNC003567 for Attorney E. Flanagan. (jmm) (Entered: 12/19/2022) (0) |
Dec 16, 2022 | 222 | CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. certifying service of Plaintiffs' Objections to Mylan's Pretrial Disclosures. (Higginbotham, Daniel) (Entered: 12/16/2022) (3) |
Dec 16, 2022 | 223 | MOTION for Leave to Appear Pro Hac Vice of Elizabeth M. Flanagan by Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # 1 Proposed Order)(Higginbotham, Daniel) (Entered: 12/16/2022) (Main Document) (5) |
Dec 16, 2022 | 223 | MOTION for Leave to Appear Pro Hac Vice of Elizabeth M. Flanagan by Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # 1 Proposed Order)(Higginbotham, Daniel) (Entered: 12/16/2022) (Proposed Order) (1) |
Dec 15, 2022 | 220 | Plaintiffs' Expert Witness Biographical Sketches Other Document filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit 1 - Trout CV, # 2 Exhibit 2 - Bugay CV, # 3 Exhibit 3 - Smith CV, # 4 Exhibit 4 - Tate CV, # 5 Exhibit 5 - Leppo CV)(Higginbotham, Daniel) (Entered: 12/15/2022) (Main Document) (9) |
Dec 15, 2022 | 221 | Expert Witness Biographical Sketches ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(O'Brien, William) (Entered: 12/15/2022) (Main Document) (7) |
Dec 15, 2022 | 221 | Expert Witness Biographical Sketches ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(O'Brien, William) (Entered: 12/15/2022) (Exhibit A) (4) |
Dec 15, 2022 | 221 | Expert Witness Biographical Sketches ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(O'Brien, William) (Entered: 12/15/2022) (Exhibit B) (10) |
Dec 15, 2022 | 221 | Expert Witness Biographical Sketches ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(O'Brien, William) (Entered: 12/15/2022) (Exhibit C) (2) |
Dec 15, 2022 | 220 | Plaintiffs' Expert Witness Biographical Sketches Other Document filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit 1 - Trout CV, # 2 Exhibit 2 - Bugay CV, # 3 Exhibit 3 - Smith CV, # 4 Exhibit 4 - Tate CV, # 5 Exhibit 5 - Leppo CV)(Higginbotham, Daniel) (Entered: 12/15/2022) (Exhibit 1 - Trout CV) (30) |
Dec 15, 2022 | 220 | Plaintiffs' Expert Witness Biographical Sketches Other Document filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit 1 - Trout CV, # 2 Exhibit 2 - Bugay CV, # 3 Exhibit 3 - Smith CV, # 4 Exhibit 4 - Tate CV, # 5 Exhibit 5 - Leppo CV)(Higginbotham, Daniel) (Entered: 12/15/2022) (Exhibit 2 - Bugay CV) (13) |
Dec 15, 2022 | 220 | Plaintiffs' Expert Witness Biographical Sketches Other Document filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit 1 - Trout CV, # 2 Exhibit 2 - Bugay CV, # 3 Exhibit 3 - Smith CV, # 4 Exhibit 4 - Tate CV, # 5 Exhibit 5 - Leppo CV)(Higginbotham, Daniel) (Entered: 12/15/2022) (Exhibit 3 - Smith CV) (4) |
Dec 15, 2022 | 220 | Plaintiffs' Expert Witness Biographical Sketches Other Document filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit 1 - Trout CV, # 2 Exhibit 2 - Bugay CV, # 3 Exhibit 3 - Smith CV, # 4 Exhibit 4 - Tate CV, # 5 Exhibit 5 - Leppo CV)(Higginbotham, Daniel) (Entered: 12/15/2022) (Exhibit 4 - Tate CV) (2) |
Dec 15, 2022 | 220 | Plaintiffs' Expert Witness Biographical Sketches Other Document filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit 1 - Trout CV, # 2 Exhibit 2 - Bugay CV, # 3 Exhibit 3 - Smith CV, # 4 Exhibit 4 - Tate CV, # 5 Exhibit 5 - Leppo CV)(Higginbotham, Daniel) (Entered: 12/15/2022) (Exhibit 5 - Leppo CV) (30) |
Nov 15, 2022 | 217 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Notice of Deposition of David E. Bugay, Ph.D.). (O'Brien, William) (Entered: 11/15/2022) (2) |
Nov 15, 2022 | 218 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Notice of Deposition of Pamela Smith, Ph.D.). (O'Brien, William) (Entered: 11/15/2022) (2) |
Nov 15, 2022 | 219 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Notice of Deposition of Bernhardt L. Trout, Ph.D.). (O'Brien, William) (Entered: 11/15/2022) (2) |
Nov 9, 2022 | 215 | *SEALED* TRANSCRIPT of Sealed Hearing held on 11/4/2022, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968.. (ck) (Entered: 11/09/2022) (0) |
Nov 9, 2022 | 216 | TRANSCRIPT PURCHASE ORDER by Astellas Pharma US, Inc. for proceedings held on 11/4/2022 before Judge Kleeh. (ck) (Entered: 11/09/2022) (2) |
Nov 4, 2022 | 210 | CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. certifying service of Plaintiffs' Notice of Deposition to Dr. William Schnizer. (Higginbotham, Daniel) (Entered: 11/04/2022) (2) |
Nov 4, 2022 | 211 | Joint Stipulation and Proposed Order Continuing Deadlines in the Scheduling Order ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (O'Brien, William) (Entered: 11/04/2022) (3) |
Nov 4, 2022 | 212 | STIPULATION CONTINUING DEADLINES IN THE SCHEDULING ORDER. Signed by Chief District Judge Thomas S Kleeh on 11/4/2022. (cmd) (Entered: 11/04/2022) (3) |
Nov 4, 2022 | 213 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh. Motion Hearing held on 11/4/2022 re 198 MOTION to Strike Defendant Mylan Pharmaceuticals Inc. Motion to Strike Plaintiffs Experts Untimely New Theories and Experimental Data Presented for the First Time in Reply Reports filed by Mylan Pharmaceuticals Inc. (Court Reporter C. Knecht.) (wrr) (Entered: 11/04/2022) (0) |
Nov 4, 2022 | 214 | DOCUMENT filed as to case participants per TSK. (wrr) (Entered: 11/04/2022) (0) |
Nov 2, 2022 | 206 | ORDER GRANTING 200 DEFENDANT'S MOTION TO FILE MEMORANDUM UNDER SEAL. Signed by Chief District Judge Thomas S Kleeh on 11/2/2022. (cmd) (Entered: 11/02/2022) (2) |
Nov 2, 2022 | 207 | DEFENDANT MYLAN PHARMACEUTICALS INC'S BRIEF IN SUPPORT OF ITS 198 MOTION to Strike Defendant Mylan Pharmaceuticals Inc. Motion to Strike Plaintiffs Experts Untimely New Theories and Experimental Data Presented for the First Time in Reply Reports filed by Mylan Pharmaceuticals Inc. Filed under seal per 206 Order. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G)(cmd) (Entered: 11/02/2022) (0) |
Nov 2, 2022 | 208 | ORDER GRANTING 203 PLAINTIFF'S MOTION TO FILE RESPONSE UNDER SEAL. Signed by Chief District Judge Thomas S Kleeh on 11/2/2022. (cmd) (Entered: 11/02/2022) (1) |
Nov 2, 2022 | 209 | PLAINTIFFS' OPPOSITION TO 198 MOTION to Strike Defendant Mylan Pharmaceuticals Inc. Motion to Strike Plaintiffs Experts Untimely New Theories and Experimental Data Presented for the First Time in Reply Reports filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K)(cmd) (Entered: 11/02/2022) (0) |
Oct 18, 2022 | 205 | ORDER SCHEDULING MOTION HEARING. Motion Hearing Re 8 Mylan Pharmaceuticals Inc. Motion to Strike Plaintiffs' Experts Untimely New Theories and Experimental Data Presented for the First Time in Reply Reports set for 11/4/2022 11:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S Kleeh. Signed by Chief District Judge Thomas S Kleeh on 10/18/2022. (dk) (Entered: 10/18/2022) (1) |
Sep 22, 2022 | 204 | Defendant Mylan Pharmaceuticals Inc.'s Reply Brief In Support of Its Motion to Strike Plaintiffs' Experts' New Theories and Experimental Data Presented for the First Time in Reply Reports ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (O'Brien, William) (Entered: 09/22/2022) (15) |
Sep 15, 2022 | 203 | MOTION to Seal by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Plf's Memorandum of Law in Support of Plfs' Motion for Leave to File Under Seal, # 2 Exhibit 1 - Plaintiffs' Opposition to Defendant Mylan's Motion to Strike, # 3 Exhibit A to Exhibit 1, # 4 Exhibit B to Exhibit 1, # 5 Exhibit C to Exhibit 1, # 6 Exhibit D to Exhibit 1, # 7 Exhibit E to Exhibit 1, # 8 Exhibit F to Exhibit 1, # 9 Exhibit G to Exhibit 1, # 10 Exhibit H to Exhibit 1, # 11 Exhibit I to Exhibit 1, # 12 Exhibit J to Exhibit 1, # 13 Exhibit K to Exhibit 1)(Higginbotham, Daniel) (Entered: 09/15/2022) (0) |
Sep 7, 2022 | 202 | Defendant's Reply In Support of Its Motion for Expedited Briefing Schedule and Expedited Hearing Date ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (O'Brien, William) (Entered: 09/07/2022) (5) |
Sep 6, 2022 | 201 | RESPONSE in Opposition re 199 MOTION to Expedite Motion of Defendant Mylan Pharmaceuticals Inc. for Expedited Briefing Schedule and Expedited Hearing Date filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Higginbotham, Daniel) (Entered: 09/06/2022) (Main Document) (7) |
Sep 6, 2022 | 201 | RESPONSE in Opposition re 199 MOTION to Expedite Motion of Defendant Mylan Pharmaceuticals Inc. for Expedited Briefing Schedule and Expedited Hearing Date filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Higginbotham, Daniel) (Entered: 09/06/2022) (Exhibit A) (2) |
Sep 6, 2022 | 201 | RESPONSE in Opposition re 199 MOTION to Expedite Motion of Defendant Mylan Pharmaceuticals Inc. for Expedited Briefing Schedule and Expedited Hearing Date filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Higginbotham, Daniel) (Entered: 09/06/2022) (Exhibit B) (4) |
Sep 2, 2022 | 198 | MOTION to Strike Defendant Mylan Pharmaceuticals Inc. Motion to Strike Plaintiffs Experts Untimely New Theories and Experimental Data Presented for the First Time in Reply Reports by Mylan Pharmaceuticals Inc.. (Copland, Gordon) (Entered: 09/02/2022) (5) |
Sep 2, 2022 | 199 | MOTION to Expedite Motion of Defendant Mylan Pharmaceuticals Inc. for Expedited Briefing Schedule and Expedited Hearing Date by Mylan Pharmaceuticals Inc.. (Copland, Gordon) (Entered: 09/02/2022) (4) |
Aug 24, 2022 | 196 | CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. certifying service of additional document production. (Higginbotham, Daniel) (Entered: 08/24/2022) (3) |
Aug 24, 2022 | 197 | CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. certifying service of Reply Expert Reports of Pamela Smith, Ph.D.; David E. Bugay, Ph.D; and Prof. Bernhardt L. Trout Ph.D.. (Higginbotham, Daniel) (Entered: 08/24/2022) (3) |
Aug 22, 2022 | 194 | Pro Hac Vice Filing fee: $ 200.00, receipt number WVNC003499 for attorney Martin Masar. (jmm) (Entered: 08/22/2022) (0) |
Aug 22, 2022 | 195 | ORDER granting 193 Motion of Martin S. Masar, III for Leave to Appear Pro Hac Vice on behalf of Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) (Entered: 08/22/2022) (1) |
Aug 19, 2022 | 193 | MOTION for Leave to Appear Pro Hac Vice (Martin S. Masar) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 08/19/2022) (Main Document) (4) |
Aug 19, 2022 | 193 | MOTION for Leave to Appear Pro Hac Vice (Martin S. Masar) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 08/19/2022) (Proposed Order) (1) |
Aug 12, 2022 | 192 | CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. certify service of Expert Reports of Michael E. Tate; Jeffrey A. Leppo, M.D; and Bernhardt L. Trout, Ph.D.. (Higginbotham, Daniel) (Entered: 08/12/2022) (2) |
Aug 11, 2022 | 190 | CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. certifying service of additional document production. (Higginbotham, Daniel) (Entered: 08/11/2022) (3) |
Aug 11, 2022 | 191 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. Rebuttal Expert Report Of William C. Schinzer, Ph.D. Concerning Non-Infringement and documents bearing bates numbers MYLANREG_0026287 through MYLANREG_0026297. (Copland, Gordon) (Entered: 08/11/2022) (2) |
Jul 22, 2022 | 189 | Certificate of Service (3) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Document Production on Defendant. (Higginbotham, Daniel) |
Jul 11, 2022 | 186 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for FINAL NONINFRINGEMENT CONTENTIONS (6.23.22). (O'Brien, William) |
Jul 11, 2022 | 187 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for FINAL INVALIDITY CONTENTIONS (6.23.22). (O'Brien, William) |
Jul 11, 2022 | 188 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for OPENING EXPERT REPORT OF WILLIAM C. SCHINZER, PH.D. (7.11.22). (O'Brien, William) |
Jul 8, 2022 | 184 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. certifying service of Opening Expert Reports for Prof. Bernhardt L. Trout, Ph.D., David E. Bugay, Ph.D., and Pamela Smith, Ph.D.. (Higginbotham, Daniel) |
Jul 8, 2022 | 185 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. certifying service of Document Production AST-LEX-LIT-MYL_00002987 - AST-LEX-LIT-MYL_00003339. (Higginbotham, Daniel) |
Jun 22, 2022 | 183 | Order (2) Docket Text:STIPULATION CONTINUING DEADLINES IN THE SCHEDULING ORDER. Signed by Chief District Judge Thomas S Kleeh on 6/22/2022. (dk) |
Jun 17, 2022 | 182 | Stipulation (3) Docket Text: STIPULATION Continuing Deadlines in the Scheduling Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Higginbotham, Daniel) |
Jun 13, 2022 | 180 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. Certifying service of Document Production SSCI00000001-1112. (Higginbotham, Daniel) |
Jun 6, 2022 | 179 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. certifying service of Plaintiffs' Final Infringement Contentions. (Higginbotham, Daniel) |
May 27, 2022 | 175 | Order on Motion for Miscellaneous Relief (2) Docket Text:ORDER GRANTING [174] MOTION TO SCHEDULE STATUS CONFERENCE. A status conference is SCHEDULED for June 13, 2022, at 3:00 p.m. The parties can access the status conference via ZoomGov video conferencing with an option to participate telephonically. Signed by Chief District Judge Thomas S Kleeh on 05/27/2022. (kam) |
May 25, 2022 | 174 | Main Document (4) Docket Text: MOTION Request for Status Conference by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit Decision in Related Case)(Copland, Gordon) |
May 25, 2022 | 174 | Exhibit Decision in Related Case (81) |
May 19, 2022 | 172 | Order (2) Docket Text:STIPULATION CONTINUING DEADLINES IN THE SCHEDULING ORDER. Signed by Chief District Judge Thomas S Kleeh on 5/19/2022. (dk) |
May 19, 2022 | 173 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Document production on 5.18.22). (O'Brien, William) |
May 18, 2022 | 171 | Stipulation (3) Docket Text: STIPULATION Continuing Deadlines in the Scheduling Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Higginbotham, Daniel) |
May 9, 2022 | 170 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Document production on 4.28.22). (O'Brien, William) |
May 4, 2022 | 169 | Order (2) Docket Text:STIPULATION CONTINUING DEADLINES IN THE SCHEDULING ORDER. The deposition of Rahul Gupta may be taken beyond the deadline for completion of fact discovery. All other fact discovery shall be completed by 5/4/2022. Signed by Chief District Judge Thomas S Kleeh on 5/4/2022. (dk) |
May 3, 2022 | 168 | Stipulation (3) Docket Text: STIPULATION Continuing Deadlines in the Scheduling Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Higginbotham, Daniel) |
Apr 25, 2022 | 167 | Certificate of Service (3) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Document Production AST-LEX-LIT_0001261-AST-LEX-LIT_00012726; AST-LEX-00336848. (Higginbotham, Daniel) |
Apr 19, 2022 | 166 | Certificate of Service (4) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. re Document Production. (Higginbotham, Daniel) |
Apr 18, 2022 | 165 | Certificate of Service (3) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. to Plaintiffs' Second Supplemental Objections and Responses to Mylan's First Set of Interrogatories (Nos. 3, 10, 11). (Higginbotham, Daniel) |
Apr 15, 2022 | 162 | Stipulation (4) Docket Text: STIPULATION Continuing Deadlines in the Scheduling Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Higginbotham, Daniel) |
Apr 15, 2022 | 163 | Stipulation and Order (4) Docket Text:STIPULATION CONTINUING DEADLINES IN THE SCHEDULING ORDER. Signed by Chief District Judge Thomas S Kleeh on 4/15/2022. (jmm) |
Apr 15, 2022 | 164 | Certificate of Service (3) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. re Document Production on 4-15-22. (Higginbotham, Daniel) |
Apr 8, 2022 | 161 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Document Production AST-LEX-LIT_00034338-AST-LEX-LIT_00034600. (Higginbotham, Daniel) |
Apr 7, 2022 | 158 | Main Document (7) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Jayita Guhaniyogi by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Apr 7, 2022 | 158 | Proposed Order (1) |
Apr 7, 2022 | 160 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [158] Motion of Jayita Guhaniyogi for Leave to Appear Pro Hac Vice on behalf of Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. Signed by Chief District Judge Thomas S Kleeh on 4/7/2022. (dk) |
Apr 6, 2022 | 157 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. of Document Production AST-LEX-LIT_00034321, AST-LEX-LIT_00034322, AST-LEX-LIT_00034328, AST-LEX-LIT_00034330, and AST_LEX-LIT_034337. (Higginbotham, Daniel) |
Apr 5, 2022 | 152 | Notice of Appearance (3) Docket Text: NOTICE of Appearance by Kimberly E Williams on behalf of Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Williams, Kimberly) |
Apr 5, 2022 | 153 | Main Document (4) Docket Text: MOTION to Withdraw as Attorney of Ashley N. Deem by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Apr 5, 2022 | 153 | Proposed Order (3) |
Apr 5, 2022 | 154 | Order on Motion to Withdraw as Attorney (3) Docket Text:ORDER GRANTING [153] MOTION FOR LEAVE TO WITHDRAW AS COUNSEL. Attorney Ashley Nichole Deem terminated. Signed by Chief District Judge Thomas S Kleeh on 4/5/2022. (dk) |
Apr 5, 2022 | 155 | Notice of Appearance (3) Docket Text: NOTICE of Appearance by John D. Pizzo on behalf of Mylan Pharmaceuticals Inc. (Pizzo, John) |
Apr 5, 2022 | 156 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for DEFENDANTS NOTICE OF DEPOSITION OF JOHN DEMAY. (Copland, Gordon) |
Apr 4, 2022 | 151 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for MYLAN PHARMACEUTICALS INC.S SUPPLEMENTAL OBJECTIONS AND RESPONSES TO PLAINTIFFS SECOND SET OF REQUESTS FOR PRODUCTION OF DOCUMENTS AND THINGS (NOS. 32-65). (Copland, Gordon) |
Mar 29, 2022 | 148 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Vincent Li by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Mar 29, 2022 | 148 | Proposed Order (1) |
Mar 29, 2022 | 150 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [148] Motion for Leave to Appear Pro Hac Vice of Vincent Li. Signed by Chief District Judge Thomas S Kleeh on 03/29/2022. (kam) |
Mar 25, 2022 | 145 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [141] Motion of Robert M. Oakes for Leave to Appear Pro Hac Vice on behalf of by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. Signed by Chief District Judge Thomas S Kleeh on 3/25/2022. (dk) |
Mar 25, 2022 | 146 | Certificate of Service (3) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. re Service of Subpoena to Apicore US LLC; Subpoena to Apicore Pharmaceuticals Private Ltd; and Document Production of Bates Nos. AST-LEX-LIT_00034107 - AST-LEX-LIT_00034318. (Higginbotham, Daniel) |
Mar 25, 2022 | 147 | Notice of Change of Address (4) Docket Text: NOTICE of Change of Address by Daniel R. Higginbotham (Higginbotham, Daniel) |
Mar 24, 2022 | 143 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6)). (O'Brien, William) |
Mar 24, 2022 | 144 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Document production on 3.4.22). (O'Brien, William) |
Mar 23, 2022 | 141 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Robert M. Oakes by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Mar 23, 2022 | 141 | Proposed Order (1) |
Mar 22, 2022 | 137 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [131] Motion for Leave to Appear Pro Hac Vice of Ryan Petty. Signed by Chief Judge Thomas S. Kleeh on 03/22/2022. (kam) |
Mar 22, 2022 | 138 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [132] Motion for Leave to Appear Pro Hac Vice of Madelyn S. McCormick. Signed by Chief Judge Thomas S. Kleeh on 03/22/2022. (kam) |
Mar 22, 2022 | 139 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [133] Motion for Leave to Appear Pro Hac Vice of John M. Farrell. Signed by Chief Judge Thomas S. Kleeh on 03/22/2022. (kam) |
Mar 22, 2022 | 140 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [134] Motion for Leave to Appear Pro Hac Vice of W. Chad Shear. Signed by Chief Judge Thomas S. Kleeh on 03/22/2022. (kam) |
Mar 21, 2022 | 131 | Main Document (5) Docket Text: MOTION for Leave to Appear pro hac vice of Ryan Petty by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Mar 21, 2022 | 131 | Proposed Order (1) |
Mar 21, 2022 | 132 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Madelyn S. McCormick by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Mar 21, 2022 | 132 | Proposed Order (1) |
Mar 21, 2022 | 133 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of John M. Farrell by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Mar 21, 2022 | 133 | Proposed Order (1) |
Mar 21, 2022 | 134 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of W. Chad Shear by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Mar 21, 2022 | 134 | Proposed Order (1) |
Mar 21, 2022 | 135 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [127] Motion for Leave to Appear Pro Hac Vice of Caitlin M. Dean. Signed by Chief Judge Thomas S. Kleeh on 03/21/2022. (kam) |
Mar 19, 2022 | 128 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs Second Set of Interrogatories (Nos. 15-19). (Copland, Gordon) |
Mar 19, 2022 | 129 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs First Set of Requests for Admission (Nos. 1-23. (Copland, Gordon) |
Mar 18, 2022 | 127 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Caitlin M. Dean by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Mar 18, 2022 | 127 | Proposed Order (1) |
Mar 14, 2022 | 126 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. Responses and Objections to Defendant's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) (TOPICS 1-38). (Higginbotham, Daniel) |
Mar 10, 2022 | 124 | Motion to Continue (3) Docket Text: Joint MOTION to Continue Deadlines in the Scheduling Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Deem, Ashley) |
Mar 10, 2022 | 125 | Order on Motion to Continue (2) Docket Text:ORDER granting [124] JOINT MOTION TO CONTINUE DEADLINES IN THE SCHEDULING ORDER. Signed by District Judge Thomas S. Kleeh on 3-10-22. (kam) |
Mar 1, 2022 | 120 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for Mylan Pharmaceuticals Inc.s Notice of Deposition to Plaintiffs Under Federal Rule of Civil Procedure 30(b)(6). (Copland, Gordon) |
Mar 1, 2022 | 121 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for Mylan Pharmaceuticals Inc.s First Supplemental Initial Invalidity Contentions. (Copland, Gordon) |
Feb 28, 2022 | 119 | Protective Order (3) Docket Text:Addendum to paragraph 5 of the [45] Protective Order. Signed by District Judge Thomas S. Kleeh on 2/28/22. (lmm) |
Feb 23, 2022 | 113 | Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Plaintiffs' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6). (Deem, Ashley) |
Feb 23, 2022 | 114 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Plaintiffs' Notice of Deposition to Mylan Laboratories Limited's Group Leader, Analytical Research and Department. (Deem, Ashley) |
Feb 23, 2022 | 115 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Plaintiffs' Notice of Deposition to Gowtham Katta. (Deem, Ashley) |
Feb 23, 2022 | 116 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Plaintiffs' Notice of Deposition to Jujjavarapu Satyanarayana. (Deem, Ashley) |
Feb 23, 2022 | 117 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Plaintiffs' Notice of Deposition to Rahul Gupta. (Deem, Ashley) |
Feb 23, 2022 | 118 | Proposed Order -- NOT PRETRIAL (3) Docket Text: Proposed Addendum to Paragraph 5 of the Protective Order re[45] Protective Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Deem, Ashley) |
Feb 16, 2022 | 108 | Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Plaintiff's Second Set of Interrogatories (Nos. 15-19). (Deem, Ashley) |
Feb 16, 2022 | 109 | Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Plaintiff's First Set of Requests for Admission(Nos. 1-23. (Deem, Ashley) |
Feb 16, 2022 | 110 | Motion to Take Deposition (3) Docket Text: MOTION to Take Deposition from Shantanu Jindal by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Deem, Ashley) |
Feb 16, 2022 | 111 | Motion to Take Deposition (3) Docket Text: MOTION to Take Deposition from Amy Lynn Martin by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Deem, Ashley) |
Feb 16, 2022 | 112 | Motion to Take Deposition (3) Docket Text: MOTION to Take Deposition from Dave Mitchell by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Deem, Ashley) |
Feb 15, 2022 | 107 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Objections and Responses to Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 32-65)). (O'Brien, William) |
Feb 11, 2022 | 103 | Other Document (18) Docket Text: Other Document Plaintiffs' Post Markman Brief filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Deem, Ashley) |
Feb 11, 2022 | 104 | Other Document (25) Docket Text: Other Document Plaintiffs' Findings of Fact and Conclusions of Law filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Deem, Ashley) |
Feb 11, 2022 | 106 | Other Document (20) Docket Text:Defendant's Claim Construction Findings of Fact and Conclusions of Law ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
Feb 4, 2022 | 102 | Transcript (63) Docket Text: TRANSCRIPT of Proceedings held on 01/14/2022, before Judge Thomas S. Kleeh. Court Reporter/Transcriber Jill M. Cutter, RPR, Telephone number 304-622-8513. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 2/25/2022. Redacted Transcript Deadline set for 3/7/2022. Release of Transcript Restriction set for 5/5/2022. (jc) |
Feb 2, 2022 | 100 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. "Mylan Pharmaceuticals Incs. Second Supplemental Objections and Responses to Plaintiffs First Set of Interrogatories". (Copland, Gordon) |
Feb 2, 2022 | 101 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. "Mylan Pharmaceuticals Inc.s Second Supplemental Initial Disclosures Pursuant to Fed. R.Civ. P. 26(a)(1)". (Copland, Gordon) |
Jan 19, 2022 | 99 | Main Document (3) Docket Text: NOTICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. of Subpoena to Mylan Laboratories Limited (Attachments: # (1) Attachment Redacted Subpoena)(Deem, Ashley) |
Jan 19, 2022 | 99 | Attachment Redacted Subpoena (44) |
Jan 14, 2022 | 97 | Order (1) Docket Text:ORDER SCHEDULING FILING DEADLINES FOR CLAIM CONSTRUCTION HEARING POST-BRIEFING AND PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW. The Court hereby ORDERS post-hearing briefs and findings of fact and conclusions of law be filed on or before February 11, 2022. Signed by District Judge Thomas S. Kleeh on 1/14/2022. (dk) (Main Document 97 replaced per Chambers on 1/14/2022. NEF regen. ) (dk). |
Dec 31, 2021 | 94 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for document production bates numbered MYLANREG_0016242 through MYLANREG_0019979. (Copland, Gordon) |
Dec 31, 2021 | 95 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for MYLAN PHARMACEUTICALS INC.S SUPPLEMENTAL INITIAL DISCLOSURES PURSUANT TO FED. R. CIV. P. 26(a)(1). (Copland, Gordon) |
Dec 31, 2021 | 96 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for "MYLAN PHARMACEUTICALS INC.S FIRST SUPPLEMENTAL OBJECTIONS AND RESPONSES TO PLAINTIFFS FIRST SET OF INTERROGATORIES". (Copland, Gordon) |
Dec 30, 2021 | 93 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. Serving Plaintiffs' Supplemental Objections and Responses to Mylan's First Set of Interrogatories (Nos. 7-8, 10, 12-13). (Higginbotham, Daniel) |
Dec 28, 2021 | 92 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. evidencing service of certain bates numbered documents. (Higginbotham, Daniel) |
Dec 22, 2021 | 91 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Document production on 12.20.21). (O'Brien, William) |
Dec 16, 2021 | 90 | Stipulation (3) Docket Text: STIPULATION of the parties on substantial completion of document discovery by Mylan Pharmaceuticals Inc.. (Copland, Gordon) |
Nov 30, 2021 | 89 | Order on Motion for Miscellaneous Relief (2) Docket Text:ORDER GRANTING JOINT MOTION REGARDING FORMAT AND DATE OF CLAIM CONSTRUCTION HEARING. The Court GRANTS the [88] Joint Motion and reschedules the Claim Construction Hearing for 1/14/2022 12:45 PM, before District Judge Thomas S. Kleeh. The parties may appear by Zoom videoconferencing. Signed by District Judge Thomas S. Kleeh on 11/30/2021. (dk) |
Nov 24, 2021 | 88 | Motion for Miscellaneous Relief (3) Docket Text: Joint MOTION REGARDING FORMAT AND DATE OF CLAIM CONSTRUCTION HEARING by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
Nov 18, 2021 | 86 | Other Document (16) Docket Text:Plaintiffs' Rebuttal Brief in Support of Their Proposed Construction for Claim 17 of RE47.301 Other Document re [83] Other Document,, [84] Other Document, filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Deem, Ashley) |
Nov 18, 2021 | 87 | Main Document (19) Docket Text: RESPONSE by Mylan Pharmaceuticals Inc. to [83] Other Document,,. (Attachments: # (1) Exhibit Ex 14 - notice of allowance, # (2) Exhibit Ex 15 - Markman trans excerpt)(Copland, Gordon) |
Nov 18, 2021 | 87 | Exhibit Ex 14 - notice of allowance (8) |
Nov 18, 2021 | 87 | Exhibit Ex 15 - Markman trans excerpt (6) |
Nov 4, 2021 | 85 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [80] Motion of Jason A. Leonard for Leave to Appear Pro Hac Vice on behalf of Astellas Pharma US, Inc., Astellas US LLC. Signed by District Judge Thomas S. Kleeh on 11/4/2021. (dk) |
Nov 2, 2021 | 82 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. re [54] Certificate of Service for Plaintiff's Supplemental Objections and Responses to Mylan's First Set of Interrogatories (Nos. 2, 3, 9, 11, and 14-16). (Higginbotham, Daniel) |
Nov 2, 2021 | 83 | Main Document (22) Docket Text: Other Document Plaintiffs' Opening Construction Brief filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 2-A, # (4) Exhibit 2-B, # (5) Exhibit 2-C, # (6) Exhibit 2-D, # (7) Exhibit 2-E, # (8) Exhibit 2-F, # (9) Exhibit 2-G, # (10) Exhibit 3, # (11) Exhibit 4, # (12) Exhibit 5, # (13) Exhibit 6, # (14) Exhibit 7, # (15) Exhibit 8, # (16) Exhibit 9, # (17) Exhibit 10, # (18) Exhibit 11, # (19) Exhibit 12, # (20) Exhibit 13, # (21) Exhibit 14)(Higginbotham, Daniel) |
Nov 2, 2021 | 83 | Exhibit 1 (18) |
Nov 2, 2021 | 83 | Exhibit 2 (9) |
Nov 2, 2021 | 83 | Exhibit 2-A (89) |
Nov 2, 2021 | 83 | Exhibit 2-B (29) |
Nov 2, 2021 | 83 | Exhibit 2-C (49) |
Nov 2, 2021 | 83 | Exhibit 2-D (19) |
Nov 2, 2021 | 83 | Exhibit 2-E (24) |
Nov 2, 2021 | 83 | Exhibit 2-F (8) |
Nov 2, 2021 | 83 | Exhibit 2-G (11) |
Nov 2, 2021 | 83 | Exhibit 3 (25) |
Nov 2, 2021 | 83 | Exhibit 4 (7) |
Nov 2, 2021 | 83 | Exhibit 5 (4) |
Nov 2, 2021 | 83 | Exhibit 6 (8) |
Nov 2, 2021 | 83 | Exhibit 7 (20) |
Nov 2, 2021 | 83 | Exhibit 8 (8) |
Nov 2, 2021 | 83 | Exhibit 9 (6) |
Nov 2, 2021 | 83 | Exhibit 10 (9) |
Nov 2, 2021 | 83 | Exhibit 11 (4) |
Nov 2, 2021 | 83 | Exhibit 12 (7) |
Nov 2, 2021 | 83 | Exhibit 13 (16) |
Nov 2, 2021 | 83 | Exhibit 14 (4) |
Nov 2, 2021 | 84 | Main Document (25) Docket Text: Other Document Mylan Pharmaceuticals Inc.'s Opening Claim Construction Brief In Support of Its Proposed Construction for Claim 17 of RE47,301 filed by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13)(O'Brien, William) |
Nov 2, 2021 | 84 | Exhibit 1 (9) |
Nov 2, 2021 | 84 | Exhibit 2 (3) |
Nov 2, 2021 | 84 | Exhibit 3 (4) |
Nov 2, 2021 | 84 | Exhibit 4 (25) |
Nov 2, 2021 | 84 | Exhibit 5 (20) |
Nov 2, 2021 | 84 | Exhibit 6 (7) |
Nov 2, 2021 | 84 | Exhibit 7 (7) |
Nov 2, 2021 | 84 | Exhibit 8 (6) |
Nov 2, 2021 | 84 | Exhibit 9 (37) |
Nov 2, 2021 | 84 | Exhibit 10 (5) |
Nov 2, 2021 | 84 | Exhibit 11 (8) |
Nov 2, 2021 | 84 | Exhibit 12 (7) |
Nov 2, 2021 | 84 | Exhibit 13 (41) |
Oct 29, 2021 | 80 | Main Document (6) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Jason A. Leonard by Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # (1) Proposed Order)(Deem, Ashley) |
Oct 29, 2021 | 80 | Proposed Order (1) |
Oct 26, 2021 | 78 | Proposed Order -- NOT PRETRIAL (2) Docket Text: Proposed Order Stipulation Granting Parties an Extension of Time to Exchange Opening Claim Construction Briefs by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Deem, Ashley) |
Oct 26, 2021 | 79 | Order (2) Docket Text:STIPULATION GRANTING PARTIES AN EXTENSION OF TIME TO EXCHANGE OPENING CLAIM CONSTRUCTION BRIEFS up to and including November 2, 2021. Signed by District Judge Thomas S. Kleeh on 10/26/2021. (dk) |
Oct 14, 2021 | 77 | Other Document (7) Docket Text: Other Document Joint Claim Construction Statement filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Deem, Ashley) |
Oct 12, 2021 | 74 | Order (1) Docket Text:ORDER ADOPTING [73] JOINT STIPULATION. Signed by District Judge Thomas S. Kleeh on 10/12/21. (mh) Modified on 10/12/2021 to replace with corrected document. NEF regen (mh). (Main Document 74 replaced on 10/12/2021) (mh). |
Oct 12, 2021 | 75 | Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Plaintiffs' Identification of Rebuttal Intrinsic and Extrinsic Evidence in Support of Plaintiffs' Construction. (Deem, Ashley) |
Oct 12, 2021 | 76 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. Defendant Mylan Pharmaceuticals Inc.s Identification of Rebuttal Evidence to Plaintiffs Proposed Claim Construction. (Copland, Gordon) |
Oct 8, 2021 | 73 | Stipulation (2) Docket Text: STIPULATION Granting Parties an Extension of Time to Exchange Rebuttal Intrinsic and Extrinsic Evidence by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Higginbotham, Daniel) |
Sep 24, 2021 | 72 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. of Defendant Mylan Pharmaceuticals Inc.s Proposed Preliminary Constructions and Initial Identification of Evidence in Support. (Copland, Gordon) |
Sep 23, 2021 | 71 | Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. Plaintiffs' Identification of Proposed Constructions for the Term Identified by Mylan as in Need of Construction. (Deem, Ashley) |
Sep 17, 2021 | 70 | Order on Motion to Withdraw as Attorney (2) Docket Text:ORDER GRANTING MOTION FOR LEAVE TO WITHDRAW AS COUNSEL re [69]. The Court GRANTS the motion to withdraw and DIRECTS the Clerk to terminate Mr. Yurkerwich, Ms. Whelan, Ms. Wigmore, Ms. Amadi, and Ms. Major. Signed by District Judge Thomas S. Kleeh on 9/17/2021. (dk) |
Sep 16, 2021 | 69 | Main Document (3) Docket Text: MOTION to Withdraw as Attorney by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Deem, Ashley) |
Sep 16, 2021 | 69 | Proposed Order (2) |
Sep 15, 2021 | 67 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. re [54] Certificate of Service for Plaintiffs' Objections and Responses to Mylan's First Set of Interrogatories (Nos. 1-16). (Deem, Ashley) |
Sep 15, 2021 | 68 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. re [55] Certificate of Service for Plaintiffs' Objections and Responses to Mylan's First Set of Requests for Production of Documents and Things (Nos. 1-55). (Deem, Ashley) |
Sep 10, 2021 | 66 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for Defendant Mylan Pharmaceuticals Incs Identification of Terms for Construction. (Copland, Gordon) |
Sep 9, 2021 | 65 | Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for Plaintiffs' Identification of Terms/Phrases for Construction. (Higginbotham, Daniel) |
Sep 2, 2021 | 63 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [61] Motion of Kelly Del Dotto for Leave to Appear Pro Hac Vice on behalf of Astellas Pharma US, Inc., Astellas US LLC. Signed by District Judge Thomas S. Kleeh on 9/2/2021. (dk) |
Sep 2, 2021 | 64 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [60] Motion of Michael J. Kane for Leave to Appear Pro Hac Vice on behalf of Astellas Pharma US, Inc., Astellas US LLC. Signed by District Judge Thomas S. Kleeh on 9/2/2021. (dk) |
Sep 1, 2021 | 60 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Michael J. Kane by Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Sep 1, 2021 | 60 | Proposed Order (1) |
Sep 1, 2021 | 61 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Kelly Del Dotto by Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Sep 1, 2021 | 61 | Proposed Order (1) |
Aug 26, 2021 | 56 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Document production on 8.19.21). (O'Brien, William) |
Aug 26, 2021 | 57 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Initial Invalidity Contentions). (O'Brien, William) |
Aug 26, 2021 | 58 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Initial Noninfringement Contentions). (O'Brien, William) |
Aug 26, 2021 | 59 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Corrected Initial Noninfringement Contentions). (O'Brien, William) |
Aug 18, 2021 | 54 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. Defendants First Set Of Interrogatories (Nos. 1-16). (Copland, Gordon) |
Aug 18, 2021 | 55 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. Defendants First Set Of Requests for the Production of Documents and Things (Nos. 1-55). (Copland, Gordon) |
Aug 4, 2021 | 52 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. Mylan Pharmaceuticals Inc.s Objections And Responses To Plaintiffs First Set Of Request For Production Of Documents And Things. (Copland, Gordon) |
Aug 4, 2021 | 53 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. Mylan Pharmaceuticals Inc.s Objections And Responses To Plaintiffs First Set Of Interrogatories. (Copland, Gordon) |
Jul 28, 2021 | N/A | Set/Reset Scheduling Order Deadlines (0) Docket Text: Set/Reset Scheduling Order Deadlines: Discovery due by 3/17/2022. (dk) |
Jul 28, 2021 | 51 | Order on Motion to Continue (4) Docket Text:ORDER TO CONTINUE DEADLINES IN THE SCHEDULING ORDER granting [50] Motion to Continue. Fact Discovery due by 3/17/2022. Markman Hearing set for 12/6/2021 11:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before District Judge Thomas S. Kleeh. Signed by District Judge Thomas S. Kleeh on 7/28/2021. (dk) Modified to correct typographical error on 7/28/2021. NEF regen (dk). |
Jul 27, 2021 | 50 | Main Document (6) Docket Text: Joint MOTION to Continue Deadlines in the Scheduling Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
Jul 27, 2021 | 50 | Proposed Order (4) |
Jul 15, 2021 | 49 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. Plaintiffs' Preliminary Infringement Contentions. (Higginbotham, Daniel) |
Jul 11, 2021 | N/A | Notice (Other) (0) Docket Text:IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM/ECF system to the Next Generation of CM/ECF (NextGen CM/ECF) on July 19, 2021. Preparing for NextGen CM/ECF is a two-step process. Step One was to upgrade your PACER account. Each attorney should have their own individual upgraded PACER account at this time. Step two will be to link your upgraded PACER account to your WVND e-filing account in the new NextGen CM/ECF system on or after July 19, 2021. Instructions for linking your account can be found here.PLEASE NOTE: The WVND CM/ECF system will be unavailable from 1:00 pm on Friday July 16, 2021 until 8:00 am Monday, July 19, 2021. An extension for electronic filing will be granted for all documents with court-imposed deadlines falling between 1:00 pm on Friday, July 16, 2021, and midnight on Sunday, July 18, 2021. All documents due during that period must be filed prior to 1:00 pm Friday, July 16, 2021, or on Monday, July 19, 2021. If you have any additional questions, please contact the PACER Service Center at 800-676-6856 or the WVND Clerks Office CM/ECF Help Desk at (304) 267-5682. (cmd) (ADI) |
Jul 2, 2021 | 47 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for First Set of Interrogatories to Mylan Pharmaceuticals Inc.. (Higginbotham, Daniel) |
Jul 2, 2021 | 48 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. for First Set of Requests for Production of Documents and Things to Mylan Pharmaceuticals Inc.. (Higginbotham, Daniel) |
Jun 19, 2021 | N/A | Notice (Other) (0) Docket Text:IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM?ECF system to Next Generation of CM/ECF (NextGen CM/ECF) on Monday, July 19, 2021. Complete information regarding the WVND NextGen CM/ECF implementation can be found here. Preparing for NextGen Cm/ECF is a two-step process. Step one was to upgrade your PACER account. Each attorney should have their own individual upgraded PACER account at this time. Step two will be to link your upgraded PACER account to your WVND e-fling account in the new NextGen CM/ECF system on or after July 19, 2021. Please log in to the WVND CM/ECF system at https://ecf.wvnd.uscourts.gov/ before July 19, 2021 to make sure you know your current WVND e-filing login and password. Do not rely on your username and password being saved in your web browser, because that method will not work with the NextGen upgrade. If you do not know your login or password or have any additional questions please call the WVND Clerks CM/ECF Office Help Desk at (304) 267-5682. (cmd) (ADI) |
Jun 11, 2021 | 45 | Protective Order (26) Docket Text:PROTECTIVE ORDER. Signed by District Judge Thomas S. Kleeh on 6/11/2021. (dk) |
Jun 11, 2021 | 46 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. Mylan ANDA document bates numbers MYLANREG_0000001 through MYLANREG_0003980. (Copland, Gordon) |
Jun 10, 2021 | 43 | Proposed Order -- NOT PRETRIAL (26) Docket Text: Proposed Protective Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Higginbotham, Daniel) |
Jun 10, 2021 | 44 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. re Plaintiffs' NDA and File Histories. (Higginbotham, Daniel) |
May 30, 2021 | N/A | Notice (Other) (0) Docket Text:IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM/ECF system to the Next Generation of CM/ECF (NextGen CM/ECF) on July 19, 2021. Complete information regarding the WVND NextGen CM/ECF implementation can be found here. Currently, many attorneys within a firm may share a single PACER account. This will no longer be allowed with the New WVND NextGen CM/ECF system because each attorney must have an individual upgraded PACER account that will be linked to their e-filing account. Shared PACER accounts cannot be used by WVND e-filing attorneys once the WVND NextGen CM/ECF system is implemented. Preparing for NextGen CM/ECF is a two-step process. Step one is to upgrade your PACER account, and step two is to link your upgraded PACER account to the WVND e-filing account in the upgraded NextGen CM/ECF system. This notice only addresses the first step because the second step cant be completed until on or after July 19, 2021. The first step is to check and see if your PACER account is an upgraded PACER account. Many PACER accounts have already been upgraded. If any of the following is true, you have un upgraded PACER account and no action is required until after the WVND NextGen CM/ECF upgrade occurs on July 19, 2021: 1) You have a an upgraded PACER account for another NextGen court; or 2) Your PACER account was created after August 10, 2014. If none of these are true, you must upgrade your legacy PACER account before you will be able to link your PACER account to your current WVND CM/ECF account for your new NextGen CM/ECF account. Additional notices will be sent later detailing how to handle the second step in this process. If you still have questions, please contact the PACER Service Center at 800-676-6856 or the WVND Clerks Office CM/ECF Help Desk at (304) 267-5682. (cmd) (ADI) |
May 26, 2021 | 42 | Claim (10) Docket Text: Plaintiff's Answer to Defendant's Counterclaims by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. (Deem, Ashley) |
May 25, 2021 | 41 | Scheduling Order (8) Docket Text:SCHEDULING ORDER: Amended Pleadings and Joinder of Parties due by 10/14/2021. Discovery due by 2/17/2022. Proposed Pretrial Order due by 12/15/2022. Final Pretrial and Settlement Conference set for 1/9/2023 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before District Judge Thomas S. Kleeh. Jury Selection and Jury Trial set for 1/24/2023 09:30 AM in Clarksburg District Judge Courtroom, 2nd Floor before District Judge Thomas S. Kleeh. Signed by District Judge Thomas S. Kleeh on 5/25/2021. (copy counsel of record)(jmm) |
May 10, 2021 | 38 | Corporate Disclosure Statement (3) Docket Text: Corporate Disclosure Statement by Mylan Pharmaceuticals Inc. identifying Corporate Parent Mylan Inc., Corporate Parent Viatris Inc. for Mylan Pharmaceuticals Inc... (O'Brien, William) |
May 10, 2021 | 39 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Initial Disclosures Pursuant to Rule 26(a)(1)). (O'Brien, William) |
May 10, 2021 | 40 | Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. re Plaintiffs' Fed. R. Civ. P. 26(A)(1) Initial Disclosures. (Deem, Ashley) |
May 6, 2021 | 37 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [34] Motion of Matthew M. Holub for Leave to Appear Pro Hac Vice on behalf of Mylan Pharmaceuticals Inc. Signed by District Judge Thomas S. Kleeh on 5/6/2021. (dk) |
May 5, 2021 | 34 | Motion for Leave to Appear (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Matthew M. Holub) by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
May 5, 2021 | 35 | Answer to Complaint (25) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. by Mylan Pharmaceuticals Inc..(O'Brien, William) |
Apr 26, 2021 | 33 | Main Document (9) Docket Text: REPORT of Rule 26(f) Planning Meeting. (Attachments: # (1) Attachment Scheduling Order Checklist)(Deem, Ashley) |
Apr 26, 2021 | 33 | Attachment Scheduling Order Checklist (2) |
Mar 30, 2021 | 32 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [30] Motion for Jitendra Malik, PH.D to Appear Pro Hac Vice on behalf of Mylan Defendant. Signed by District Judge Thomas S. Kleeh on 3/30/21. (mh) |
Mar 27, 2021 | 30 | Main Document (3) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Jitendra Malik) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
Mar 27, 2021 | 30 | Proposed Order (1) |
Mar 23, 2021 | 21 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [10] Motion for Brittany Amadi to Appear Pro Hac Vice on behalf of Astellas Plaintiffs. Signed by District Judge Thomas S. Kleeh on 3/23/21. (mh) |
Mar 23, 2021 | 22 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [12] Motion for Lisa M. Ferri to appear Pro Hac Vice on behalf of Gilead Plaintiff. Signed by District Judge Thomas S. Kleeh on 3/23/21. (mh) |
Mar 23, 2021 | 23 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [11] Motion for Amanda L. Major to Appear Pro Hac Vice on behalf of Astellas Plaintiffs. Signed by District Judge Thomas S. Kleeh on 3/23/21. (mh) |
Mar 23, 2021 | 24 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [16] Motion for Deepro R. Mukerjee to Appear Pro Hac Vice on behalf of Mylan. Signed by District Judge Thomas S. Kleeh on 3/23/21. (mh) |
Mar 23, 2021 | 25 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [17] Motion for Lance A. Soderstrom to Appear Pro Hac Vice on behalf of Mylan. Signed by District Judge Thomas S. Kleeh on 3/23/21. (mh) |
Mar 23, 2021 | 26 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [13] Motion for Manuel J. Velez to Appear Pro Hac Vice on behalf of Gilead Plaintiff. Signed by District Judge Thomas S. Kleeh on 3/23/21. (mh) |
Mar 23, 2021 | 27 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [14] Motion for Emily Whelan to Appear Pro Hac Vice on behalf of Astellas Plaintiffs. Signed by District Judge Thomas S. Kleeh on 3/23/21. elan(mh) |
Mar 23, 2021 | 28 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [15] Motion for Amy Wigmore to Appear Pro Hac Vice on behalf of Astellas Plaintiffs. Signed by District Judge Thomas S. Kleeh on 3/23/21. (mh) |
Mar 23, 2021 | 29 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [9] Motion for Kevin M. Yurkerwich to Appear Pro Hac Vice on behalf of Astellas Plaintiffs. Signed by District Judge Thomas S. Kleeh on 3/23/21. (mh) |
Mar 22, 2021 | 16 | Main Document (3) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Deepro R. Mukerjee) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
Mar 22, 2021 | 16 | Proposed Order (1) |
Mar 22, 2021 | 17 | Main Document (3) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Lance A. Soderstrom) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
Mar 22, 2021 | 17 | Proposed Order (1) |
Mar 19, 2021 | 9 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Kevin Yurkerwich by Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # (1) Proposed Order)(Deem, Ashley) |
Mar 19, 2021 | 9 | Proposed Order (1) |
Mar 19, 2021 | 10 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Brittany Amadi by Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # (1) Proposed Order)(Deem, Ashley) |
Mar 19, 2021 | 10 | Proposed Order (1) |
Mar 19, 2021 | 11 | Main Document (5) Docket Text: MOTION for Leave to Appear pro hac vice of Amanda Major by Astellas US LLC. (Attachments: # (1) Proposed Order)(Deem, Ashley) |
Mar 19, 2021 | 11 | Proposed Order (1) |
Mar 19, 2021 | 12 | Main Document (5) Docket Text: MOTION for Leave to Appear pro hac vice of Lisa Ferri by Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Deem, Ashley) |
Mar 19, 2021 | 12 | Proposed Order (1) |
Mar 19, 2021 | 13 | Main Document (5) Docket Text: MOTION for Leave to Appear pro hac vice of Manuel J. Velez by Gilead Sciences, Inc.. (Attachments: # (1) Proposed Order)(Deem, Ashley) |
Mar 19, 2021 | 13 | Proposed Order (1) |
Mar 19, 2021 | 14 | Main Document (5) Docket Text: MOTION for Leave to Appear pro hac vice of Emily Whelan by Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # (1) Proposed Order)(Deem, Ashley) |
Mar 19, 2021 | 14 | Proposed Order (1) |
Mar 19, 2021 | 15 | Main Document (5) Docket Text: MOTION for Leave to Appear pro hac vice of Amy Wigmore by Astellas Pharma US, Inc., Astellas US LLC. (Attachments: # (1) Proposed Order)(Deem, Ashley) |
Mar 19, 2021 | 15 | Proposed Order (1) |
Mar 11, 2021 | 8 | FirstOrder (5) Docket Text:FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 4/12/2021. Rule 26 Meeting Report due by 4/26/2021. Discovery due by 5/10/2021. Signed by District Judge Thomas S. Kleeh on 3/11/21. (mh) |
Mar 10, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. Mylan Pharmaceuticals Inc. waiver sent on 3/9/2021, answer due 5/10/2021. (Higginbotham, Daniel) |
Mar 9, 2021 | 6 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Pharmaceuticals Inc. (Copland, Gordon) |
Mar 8, 2021 | 5 | Other Document (2) Docket Text:Summons in a Civil Action Other Document re [1] Complaint, filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Higginbotham, Daniel) |
Mar 5, 2021 | 3 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Astellas Pharma US, Inc., Astellas US LLC. (Higginbotham, Daniel) |
Mar 5, 2021 | 4 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Gilead Sciences, Inc.. (Higginbotham, Daniel) |
Mar 4, 2021 | 1 | Main Document (12) Docket Text: COMPLAINT against Mylan Pharmaceuticals Inc., filed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.Filing Fee $402. Receipt #0424-3216119. (Attachments: # (1) Exhibit A - Patent Information, # (2) Exhibit B - Patent Information, # (3) Exhibit C - Patent Information, # (4) Exhibit D - Prescribing Information, # (5) Civil Cover Sheet)(mh) |
Mar 4, 2021 | 1 | Exhibit A - Patent Information (22) |
Mar 4, 2021 | 1 | Exhibit B - Patent Information (22) |
Mar 4, 2021 | 1 | Exhibit C - Patent Information (20) |
Mar 4, 2021 | 1 | Exhibit D - Prescribing Information (18) |
Mar 4, 2021 | 1 | Civil Cover Sheet (1) |
Mar 4, 2021 | 2 | Report Re: Patent/Trademark (1) Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [1] Complaint. (mh) |
Mar 4, 2021 | 1 | Complaint* (1) |